1. Market Research
  2. > Pharmaceutical Market Trends
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

  • March 2018
  • 273 pages
  • ID: 1604733
  • Format: PDF
  • By BCC Research

Summary

Table of Contents

Report Scope:
The primary objective of this report is to provide in-depth knowledge of the global pharmaceutical and biopharmaceutical contract manufacturing, research and packaging market. The contract manufacturing segment is further analyzed by various dosage forms, over-the-counter (OTC) options and nutraceuticals, and drug delivery technologies. The drug discovery and development segments of pharmaceutical research through outsourcing have been analyzed under contract research market. The clinical research segment is further analyzed on the basis of preclinical and clinical research. Adaptive clinical trials have also been discussed. The contract packaging market covers primary, secondary and tertiary packaging. To analyze the primary packaging market, primary containers are categorized as blisters, bottles and others (e.g., prefillable-syringes, inhalers, vials and ampoules, caps and closures, dosing droppers, labels, accessories).

The scope of the study is global. BCC Research analyzes each market and its application, regulatory environment, new products and advancements, market projections and market shares.

The report also includes relevant patent analysis and comprehensive profiles of companies that lead the contract manufacturing market. It covers applications of outsourcing in the contract manufacturing market and contract research market. Pharmaceuticals (small molecules) and biopharmaceuticals (biologics) are the end users considered in this report. The need for outsourcing, the technology involved, and the driving and restricting factors are presented.

Report Includes:
- 50 data tables
- An overview of the global market for contract pharmaceutical manufacturing, research, and packaging, with emphasis on the outlook of the market and a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry
- Analyses of global market trends, with data from 2015, 2016, and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Examination of the effects on market growth of state-of-the-art packaging facilities, as well as expensive research facilities and the capabilities of research organizations
- Coverage of the market’s need for outsourcing, the regulatory environment, and technological issues, including the latest trends and developments
- Profiles of major companies in the market, including AbbVie Contract Manufacturing, Alkermes Plc, Catalent Inc., Dishman Pharmaceuticals and Chemicals Limited, Jubilant Life Sciences Limited and Norwich Pharma Services

Summary
The nascent pharmaceutical industry of the early 20th century was comprised of the companies with drug manufacturing, marketing and distribution under one roof. The advent of the “wonder drug” penicillin during World War II changed human and animal life expectancy and also paved the way to the mass production of pharmaceuticals. The development of new instruments and assay techniques after World War II found rapid application in the realm of medicine as research into general physiology and therapeutics prospered. After the 1950s, technological advances coupled with the understanding of molecular science opened the door for innovation in the pharmaceutical industry. The 21st century brought patent-protected innovative targeted biopharmaceuticals into the market. This also presented tough economic realities to small-molecule manufacturers in the form of expiring patents, growing threats to intellectual property, stringent regulations, shrinking pipelines, constricting profit margins and fierce competition. To deal with these issues, pharmaceutical companies started forming collaborations with contract manufacturing organizations (CROs). They also pursued mergers and acquisitions, as well as joint venture strategies, to get access to other markets.

The pharmaceutical industry, a highly innovation-driven industry, is knowledge-intense, highly globalized and diversified. It brings massive benefits to the public health and to the economy by bringing out inventive therapies. Pharmaceutical companies squeezed by healthcare providers and governments on pricing and patent cliff approached contract manufacturing organizations to maintain their positions in this highly competitive environment. The peak of the patent cliff has passed, and research and development productivity is increasing in the industry. Outsourcing that has been transformed from “pay for services” to “partnerships and collaborations” is considered the most successful strategy to bring innovation into the drug industry. Strategic partnerships are now prevalent during all aspects of the research and development (R&D) cycle. In contrast to the traditional outsourcing model, this strategic partnership model shares the risks and rewards of innovation.

The need for contract manufacturers for pharmaceutical manufacturing arose from the increasing demand of pharmaceutical products due to growing aging populations and more incidence of chronic diseases. Pharmaceutical manufacturers wish to gain access to new manufacturing and drug delivery technologies without investment, and their need to reduce the manufacturing costs are further driving the contract manufacturing and research in pharmaceutical landscape. Mr. Biswajeet Sahu, Associate Vice President, Wockhardt Ltd., Mumbai, India, stated, “Both technology and regulatory are going to play very pivotal role as far as the quality system in manufacturing is concerned. If I may talk about technology specifically, we need zero defect products; that means any company would like to have a zero-defect product and that can be achieved only when you have a technology with minimum human intervention. So, the science of engineering is moving to more of robotics and less interventions by human beings, where there are chances of committing errors; so that is how the technology is moving forward.” Boots Contract Manufacturing, Patheon N.V., Catalent Pharma Solutions and Lonza are some of the leading CMOs in the bio/pharmaceutical industry.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020

Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020

Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020Summaryclinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2020" provides an overview of Anaplastic Astrocytoma ...

Global Ophthalmology Therapeutics Market 2020-2024

Global Ophthalmology Therapeutics Market 2020-2024

  • $ 2500
  • January 2020

Global Ophthalmology Therapeutics Market 2020-2024The analyst has been monitoring the global ophthalmology therapeutics market and it is poised to grow by USD 10.42 bn during 2020-2024, progressing at ...

Enteral Feeding Devices Market to 2027 - Global Analysis and Forecasts By Product ; Material ; Age Group ; Application ; End User, and Geography

Enteral Feeding Devices Market to 2027 - Global Analysis and Forecasts By Product ; Material ; Age Group ; Application ; End User, and Geography

  • $ 4550
  • January 2020

The global enteral feeding devices market is expected to reach US$ 4,034.42 Mn in 2027 from US$ 2,359.06 Mn in 2018. The market is estimated to grow with a CAGR of 6.2% from 2019-2027.The factors driving ...


ref:plp2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on